Skip to content

CS Professional · Intellectual Property Rights - Law and Practice · Protection of Trade Secrets

Kiran Pharma shares a confidential synthesis route with Orion Labs under a written contract containing a confidentiality clause but no mention of any statute. Orion leaks the route. Which analysis best fits the Indian legal position on the nature of the right?

Kiran can sue Orion under the contractual confidentiality clause and under the equitable doctrine of breach of confidence. India has no dedicated trade secret statute and no registration system, so protection rests on contract, common law and equity, supplemented by other laws.

  1. AKiran has no remedy because India has no dedicated trade secret statute and contracts cannot cover secrets
  2. BKiran can sue only under the Patents Act, 1970, as trade secrets are a category of patents
  3. CKiran can rely on contract law and the equitable doctrine of breach of confidence, even without a dedicated trade secret statuteCorrect
  4. DKiran can sue only if the route was first registered as a trade secret with the Registrar of Trade Marks

Explanation

India has no standalone trade secret statute. Protection is built on contract law, equitable principles of breach of confidence, and related laws such as copyright and the Information Technology Act. Option A ignores these routes, B and D invent registration or patent status.

Did you get it right without looking?

One question tells you little. A timed set on Protection of Trade Secrets shows your real accuracy, how long you take and where you lose marks.

Practise Protection of Trade SecretsFree diagnostic mock

More Protection of Trade Secrets questions